Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine

About this trial

The goal of this study is to find out whether phycocyanin, a natural protein from spirulina, can help protect the liver and support recovery in adults having part of their liver removed. The study will also look at whether phycocyanin is safe to take.The main questions are:

Does phycocyanin reduce liver injury after surgery? Does it help the liver grow back and recover? What side effects or medical problems happen while taking it?

Researchers will compare phycocyanin with a placebo, which looks similar but does not contain phycocyanin. About 30 people will take part. Each person will be randomly placed into one of the two groups, and neither the participants nor the researchers will know which treatment each person receives during the study.

Participants will:

Take 1.5 grams of phycocyanin or placebo every day for 3 weeks before surgery and 3 weeks after surgery Receive the usual care for liver surgery Give blood and stool samples before and after treatment Allow researchers to study a small piece of liver tissue removed during surgery Return for follow-up for up to 90 days after surgery

The samples will be used to check liver function, inflammation, gut bacteria, and changes linked to liver healing. Possible side effects include an allergic reaction or stomach discomfort. The study has been approved by an ethics committee.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of intrahepatic cholangiocarcinoma

Child-Pugh class A liver function

Planned neoadjuvant treatment with gemcitabine plus oxaliplatin, lenvatinib, and a PD-1 inhibitor

Planned anatomical hemihepatectomy with an expected future liver remnant greater than 40%

Disqualifiers

Serious coexisting medical conditions

Known allergy to phycocyanin

Other malignant tumors

Previous liver resection

Trial design

Design model

Parallel

Treatments tested in this trial

  • Phycocyanin

    Dietary supplement

    Participants will take 1.5 grams of phycocyanin by mouth once daily for 3 weeks before partial hepatectomy and for 3 weeks after surgery. Phycocyanin is a natural protein from spirulina.

  • Maltodextrin

    Dietary supplement

    Participants will take 1.5 grams of maltodextrin placebo by mouth once daily for 3 weeks before partial hepatectomy and for 3 weeks after surgery. The placebo does not contain phycocyanin.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Phycocyanin GroupExperimental treatment 1 intervention
Group B: Placebo GroupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Serum Aspartate Aminotransferase (AST) Level

Time frame
Baseline and Week 3 after surgery
2

Change in Serum Alanine Aminotransferase (ALT) Level

Time frame
Baseline and Week 3 after surgery
3

Change in Serum Total Bilirubin (TBIL) Level

Time frame
Baseline and Week 3 after surgery

Secondary outcomes

1

Change in Blood Inflammatory Marker Levels

Time frame
Baseline and Week 3 after surgery
2

Liver Cell Proliferation Assessed by Ki-67 Expression

Time frame
Baseline and Week 3 after surgery
3

Liver Cell Proliferation Assessed by PCNA Expression

Time frame
Baseline and Week 3 after surgery

Other outcomes

1

Incidence of Treatment-Emergent Adverse Events

Time frame
through study completion, an average of 1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.